首页 | 官方网站   微博 | 高级检索  
     

倍他乐克对扩张型心肌病病人P波离散度及最大P波时限的影响
引用本文:郑斌,靳雪琴,党瑜华.倍他乐克对扩张型心肌病病人P波离散度及最大P波时限的影响[J].中国基层医药,2001,8(3):260-261.
作者姓名:郑斌  靳雪琴  党瑜华
作者单位:1. 解放军289医院内二科,侯马,043000
2. 河南医科大学第一附属医院心内科
摘    要:目的:观察倍他乐克对扩张型心肌病病人P波离散度及最大P波时限的影响,方法:扩张型心肌病病人分为对照组与干预组,干预组口服倍乐克治疗,12导联心电图中P波最大时限与最短时限的差值为P波离散度,结果:扩张型心肌病病人的P波离散度及最大P波时限较正常人明显延长,干预组口服倍他乐克后P波离散度及最大P波时限较给药前明显缩短。结论:倍他乐克可降低扩张型心肌病病人的P波离散度及最大P波时限,从而减少房性心律失常的发生,改善预后。

关 键 词:美托洛尔  扩张型心肌病  心电描记术  心律失常  P波离散度  最大P波时限
修稿时间:2000年6月27日

The effect of metoprolol on Pdisp and Pamx in dilated cardiomyopathy patients
ZHENG Bin,JIN Xueqin,DANG Yuhua.The effect of metoprolol on Pdisp and Pamx in dilated cardiomyopathy patients[J].Chinese Journal of Primary Medicine and Pharmacy,2001,8(3):260-261.
Authors:ZHENG Bin  JIN Xueqin  DANG Yuhua
Affiliation:ZHENG Bin,JIN Xueqin,DANG Yuhua.The PLA's 289 Hospital,Houma,043000
Abstract:Objective To observe the effect of metoprolol on Pdisp and Pmax in dilated cardiomyopathy patients.Methods All patients were divided into two groups, the control and the metoprolol groups. Pdisp is described as the difference between Pmax and Pmin.Results Pdisp and Pmax in dilated cardiomyopathy patients were longer than ordinary people. Pdisp and Pmax in dilated cardiomyopathy patients after metoprolo treatment were shorter than before.Conclusion Metoprolol can decrease Pdisp and Pmax in dilated cardiomyopathy patients, which may reduce the incidence of atrial arrhythmia.
Keywords:Metoprolol Cardiomyopathy Congestive  Electrocardiography  Arrhythmia
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号